XML 33 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Note 13 - Employee Stock Option and Retirement Plans
6 Months Ended
Feb. 28, 2019
Notes to Financial Statements  
Compensation and Employee Benefit Plans [Text Block]
1
3
. EMPLOYEE STOCK OPTION AND RETIREMENT PLANS
 
Stock Option Awards
 
The FactSet Research Systems Inc. Stock Option and Award Plan, as Amended and Restated (the “Long Term Incentive Plan” or “LTIP”) provides for the grant of share-based awards, including stock options and restricted stock awards to employees of FactSet. The expiration date of the Long Term Incentive Plan is
December 19, 2027.
Stock options granted under the LTIP expire
not
more than
ten
years from the date of grant and the majority vest ratably over a period of
five
years. Options become vested and exercisable provided the employee continues employment with the Company through the applicable vesting date and remain exercisable until expiration or cancellation. Options are
not
transferable or assignable other than by will or the laws of descent and distribution. During the grantee’s lifetime, the options
may
be exercised only by the grantee.
 
S
tock Option Activity
 
During the
first
six
months of fiscal
2019,
FactSet granted
460,713
stock options with a weighted average exercise price of
$221.74
to existing employees of the Company.
 
A summary of stock option activity for the
six
months ended
February 28, 2019
is as follows:
 
 
(in thousands, except per share data)
 
Number of
Stock Options
Outstanding
   
Weighted Average
Exercise Price Per Share
 
Balance at August 31, 2018
   
3,143
    $
153.05
 
Granted – non-performance-based
   
455
     
221.93
 
Exercised
   
(117
)    
132.81
 
Forfeited
   
(24
)    
169.47
 
Balance at November 30, 2018
   
3,457
    $
162.68
 
Granted – non-performance-based
   
6
     
207.84
 
Granted – non-employee Directors’ grant
   
21
     
207.88
 
Exercised
   
(207
)    
136.30
 
Forfeited
   
(61
)    
152.19
 
Balance at February 28, 2019
   
3,216
    $
164.42
 
 
The total number of in-the-money options exercisable as of
February 28, 2019
was
1.2
million with a weighted average exercise price of
$138.41.
The aggregate intrinsic value of in-the-money stock options exercisable at
February 28, 2019
and
August 31, 2018
was
$116.5
million and
$105.3
million, respectively. The aggregate intrinsic value represents the difference between the Company’s closing stock price as of
February 28, 2019
of
$235.17,
and the exercise price, multiplied by the number of options exercisable as of that date.
 
The total pre-tax intrinsic value of stock options exercised during the
three
months ended
February 28, 2019
and
2018
was 
$15.5
million and
$17.2
million, respectively. The total pre-tax intrinsic value of stock options exercised during the
six
months ended
February 28, 2019
and
2018
was
$26.3
million and
$35.2
million, respectively.
 
Performance-based
Equity Awards
 
Performance-based equity awards, whether in the form of stock options or restricted stock, require management to make assumptions regarding the likelihood of achieving Company performance targets. The number of performance-based awards that vest will be predicated on the Company achieving performance levels during the measurement period subsequent to the date of grant. Dependent on the financial performance levels attained by FactSet, a percentage of the performance-based awards will vest to the grantees. However, there is
no
current guarantee that such awards will vest in whole or in part.
 
The following summarizes the material performance-based award outstanding as of
February 28, 2019.
 
June 2017
Performance-based Option Grant Review
In connection with the acquisition of BISAM, FactSet granted
206,417
performance-based stock options in
June 2017.
These performance-based options will vest
40%
on the
second
anniversary date of the grant and
20%
on each subsequent anniversary date if certain BISAM revenue and operating income targets are achieved by
March 31, 2019.
The option holders must also remain employed by FactSet for the options to be eligible to vest. As of
February 28, 2019,
FactSet does
not
believe these growth targets are probable of being achieved, and as such,
no
stock-based compensation expense is expected to be recognized in connection with these performance-based options. A change in the actual financial performance levels achieved by BISAM in future fiscal years could result in the following changes to the current estimate of the vesting percentage and related expense:
 
Vesting Percentage
(in thousands)
   
Cumulative
Catch-up Adjustment*
 
Remaining Expense
to be Recognized
0% (current expectation)
    $
    $
 
80%     $
2,369
    $
4,738
 
90%     $
2,665
    $
5,331
 
100%     $
2,961
    $
5,923
 
 
* Amounts represent the cumulative catch-up adjustment to be recorded if there
were
a change in the vesting percentage as of
February 28
,
201
9
 
Restricted Stock Awards
 
The Company’s Option Plan permits the issuance of restricted stock awards in the form of either restricted shares or restricted stock units. Restricted stock awards are subject to continued employment over a specified period.
 
Restricted Stock Awards Activity
 
During the
first
six
months of fiscal
2019,
FactSet granted
41,153
restricted stock awards to employees of the Company at a weighted average grant date fair value of
$212.66.
These restricted stock awards vest over a weighted average period of
5.0
years from grant date.
 
As of
February 28, 2019,
a total of
106,558
restricted stock awards were unvested and outstanding, which results in unamortized stock-based compensation of
$16.1
million to be recognized as stock-based compensation expense over the remaining weighted average vesting period of
3.6
years.
 
A summary of restricted stock award activity is as follows:
 
(in thousands, except per award data)
 
 
Number Outstanding
   
Weighted Average Grant
Date Fair Value Per Award
 
                   
Balance at August 31, 2018
   
143
 
    $
139.34
 
Granted
   
41
 
    $
212.66
 
Forfeited
   
(1
)
    $
200.18
 
Vested
   
(52
)
(1)
    $
113.44
 
Balance at November 30, 2018
   
131
 
    $
172.48
 
Granted
   
 
    $
 
Forfeited
   
(1
)
    $
184.64
 
Vested
   
(23
)
(2)
    $
136.58
 
Balance at February 28, 2019
   
107
 
    $
187.62
 
 
 
(
1
)
The
majority of the vested
restricted stock
awards
relate
d
to
the final vesting of
awards
grant
ed
on
November 1, 2013
,
which cliff vested
6
0%
after
three
years o
n
November 1, 2016
and
4
0%
after
five
years on
November 1, 2018.
 
 
(
2
)
The majority of the vested restricted stock awards related to the final vesting of awards granted on
February 9, 2015,
which vested
100%
on the
four
year anniversary date of the grant.
 
As of
February 28, 2019,
and
August 31, 2018,
the aggregate fair value of unvested restricted stock was
$25.1
million and
$32.8
million, respectively. Aggregate fair value of unvested restricted stock represents the Company’s closing stock prices of
$235.17
and
$229.39
on
February 28, 2019
and
August 31, 2018,
respectively, multiplied by the number of unvested restricted stock as of that date.
 
The total pre-tax fair value of restricted stock that vested during the
three
months ended
February 28, 2019
and
2018
was
$5.1
million and
$0.7
million, respectively. The total pre-tax fair value of restricted stock that vested during the
six
months ended
February 28, 2019
and
2018
was
$16.7
million and
$2.7
million, respectively.
 
Share-based Awards Available for Grant
 
A summary of share-based awards available for grant is as follows:
 
 
(in thousands)
 
Share-based Awards
Available for Grant under the
Employee Stock Option Plan
   
Share-based Awards
Available for Grant under the
Non-Employee Stock Option Plan
 
Balance at August 31, 2018
   
6,298
     
282
 
Granted – non-performance-based options
   
(455
)    
 
Restricted stock awards granted
(1)
   
(103
)    
 
Share-based awards canceled/forfeited
(2)
   
25
     
 
Balance at November 30, 2018
   
5,765
     
282
 
Granted – non-performance-based options
   
(6
)    
(21
)
Share-based awards canceled/forfeited
(2)
   
65
     
3
 
Balance at February 28, 2019
   
5,824
     
264
 
 
 
(
1
)
Each restricted stock award granted is equivalent to
2.5
shares granted under the Company’s Option Plan.
 
 
(
2
)
Under the Company’s Option Plan, for each restricted stock award canceled/forfeited, an equivalent of
2.5
shares is added back to the available share-based awards balance.
 
Employee Stock Purchase Plan
 
Shares of FactSet common stock
may
be purchased by eligible employees under the Amended and Restated FactSet Research Systems Inc. Employee Stock Purchase Plan, as Amended and Restated (the “ESPP”) in
three
-month intervals. The purchase price is equal to
85%
of the lesser of the fair market value of the Company’s common stock on the
first
day or the last day of each
three
-month offering period. Employee purchases
may
not
exceed
10%
of their gross compensation and a
$25,000
contribution limit during an offering period.
 
During the
three
months ended
February 28, 2019,
employees purchased
12,624
shares at a price of
$199.36
compared to
14,805
shares at a price of
$171.23
for the
three
months ended
February 28, 2018.
During the
six
months ended
February 28, 2019,
employees purchased
25,719
shares at a price of
$198.33
as compared to
34,394
shares at a price of
$150.25
for the
six
months ended
February 28, 2018.
At
February 28, 2019,
the ESPP had
243,223
shares reserved for future issuance.
 
Employee Benefit Plans
 
FactSet sponsors benefit plans for the majority of its domestic and foreign employees. The Company contributed
$2.6
million in employer matching contributions for its U.S. defined contribution plan for both the
three
months ended
February 28, 2019
and
2018.
During the
six
months ended
February 28, 2019
and
2018,
the Company contributed
$5.2
million and
$5.5
million in employer matching contributions for its U.S. defined contribution plan, respectively. Contributions to foreign benefit plans were
not
material to FactSet on either an individual or aggregate basis for any of the periods presented.